| Dr David Jacob Weinstock, DMD | |
|
15 Presidential Blvd, Suite 201, Bala Cynwyd, PA 19004-1006 | |
| (610) 667-2770 | |
| (610) 667-3833 |
| Full Name | Dr David Jacob Weinstock |
|---|---|
| Gender | Male |
| Speciality | Dentist |
| Location | 15 Presidential Blvd, Bala Cynwyd, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205977402 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | DS025783L (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Jacob Weinstock, DMD 1206 Lakemont Rd, Villanova, PA 19085-2104 Ph: (610) 525-2974 | Dr David Jacob Weinstock, DMD 15 Presidential Blvd, Suite 201, Bala Cynwyd, PA 19004-1006 Ph: (610) 667-2770 |
News Archive
The latest NPS MedicineWise case study Type 2 diabetes: tailoring ongoing treatment has been launched in a new dynamic online format. The case study focuses on available treatment options for a 75-year-old male with type 2 diabetes and offers continuing professional development points for GPs, pharmacists and nurses.
At an international gathering of TB vaccine researchers in Tallinn today, the Aeras Global TB Vaccine Foundation announced it will initiate a clinical trial of an investigational live recombinant tuberculosis vaccine to be led by researchers at Saint Louis University in St. Louis, Missouri, USA. The announcement was made at the Second Global Forum on TB Vaccine Development.
The University of Illinois at Chicago has received a $12.4 million grant from the National Cancer Institute to study the predictors of smoking patterns from adolescence through young adulthood.
The Bioproduction Facility at Cornell University has produced the first batch of NY-ESO-1 recombinant protein-a cancer vaccine-that will be used in clinical trials for patients facing either ovarian cancer or melanoma. The facility was developed as a partnership between The Ludwig Institute for Cancer Research and Cornell University.
EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany, announced today the online publication of the results from the CLARITY Phase III trial using Cladribine Tablets (EMD Serono's proprietary investigational oral formulation of cladribine) in The New England Journal of Medicine. The CLARITY study was a two-year (96-week), randomized, double-blind, placebo-controlled Phase III trial of Cladribine Tablets in 1,326 people with relapsing-remitting multiple sclerosis (MS).
› Verified 3 days ago
Dr. Agata Lewkowska, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 15 Presidential Blvd, Suite #303, Bala Cynwyd, PA 19004 Phone: 610-660-9510 Fax: 610-660-9512 | |
Dr. Tiffany Morgan, D.M.D Dentist Medicare: Medicare Enrolled Practice Location: 301 E City Ave, Sutie G5, Bala Cynwyd, PA 19004 Phone: 610-660-9510 Fax: 215-646-6166 | |
Lyusya R Badishyan, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 301 E City Ave, Suite G5, Bala Cynwyd, PA 19004 Phone: 610-660-9510 | |
Dr. Steven Schlesinger, D.M.D. Dentist Medicare: Medicare Enrolled Practice Location: 115 Conshohocken State Rd, Bala Cynwyd, PA 19004 Phone: 610-664-3383 | |
Andrew Marinchenko, DMD Dentist Medicare: Medicare Enrolled Practice Location: 191 Presidential Blvd, W-4, Bala Cynwyd, PA 19004 Phone: 610-664-3636 Fax: 610-664-5060 | |
Dr. Ashley O'brien, Dentist Medicare: Not Enrolled in Medicare Practice Location: 187 W City Ave, Bala Cynwyd, PA 19004 Phone: 607-342-8654 | |
Hamida Shirazy, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 15 Presidential Blvd, Suite#303, Bala Cynwyd, PA 19004 Phone: 610-660-9510 Fax: 610-660-9512 |